Cargando…

Consensus on the clinical management, screening‐to‐treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale

BACKGROUND: Previous international consensus statements provided general policies for the management of Helicobacter pylori infection. However, there are geographic differences in the prevalence and antimicrobial resistance of H. pylori, and in the availability of medications and endoscopy. Thus, na...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheu, Bor‐Shyang, Wu, Ming‐Shiang, Chiu, Cheng‐Tang, Lo, Jing‐Chuan, Wu, Deng‐Chyang, Liou, Jyh‐Ming, Wu, Chun‐Ying, Cheng, Hsiu‐Chi, Lee, Yi‐Chia, Hsu, Ping‐I, Chang, Chun‐Chao, Chang, Wei‐Lun, Lin, Jaw‐Town
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434958/ https://www.ncbi.nlm.nih.gov/pubmed/28066960 http://dx.doi.org/10.1111/hel.12368

Ejemplares similares

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A Nationwide Study
por: Liou, Jyh-Ming, et al.
Publicado: (2015)

Consensus on Control of Risky Nonvariceal Upper Gastrointestinal Bleeding in Taiwan with National Health Insurance
por: Sheu, Bor-Shyang, et al.
Publicado: (2014)

Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
por: Tsai, Kun-Feng, et al.
Publicado: (2017)

Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy
por: Liou, Jyh-Ming, et al.
Publicado: (2022)

The interplay between Helicobacter pylori and gastrointestinal microbiota
por: Chen, Chieh-Chang, et al.
Publicado: (2021)

Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis
por: Kao, Cheng-Yen, et al.
Publicado: (2016)

Toward population specific and personalized treatment of Helicobacter pylori infection
por: Liou, Jyh-Ming, et al.
Publicado: (2018)

H. pylori isolates with amino acid sequence polymorphisms as presence of both HtrA-L171 & CagL-Y58/E59 increase the risk of gastric cancer
por: Yeh, Yi-Chun, et al.
Publicado: (2019)

Helicobacter pylori with stronger intensity of CagA phosphorylation lead to an increased risk of gastric intestinal metaplasia and cancer
por: Chuang, Chiao-Hsiung, et al.
Publicado: (2011)

Matrix metalloproteinase-3 promoter polymorphisms but not dupA-H. pylori correlate to duodenal ulcers in H. pylori-infected females
por: Yeh, Yi-Chun, et al.
Publicado: (2010)

Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical Considerations
por: Lee, Yi-Chia, et al.
Publicado: (2016)

The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention
por: Lee, Yi-Chia, et al.
Publicado: (2013)

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
por: Liou, Jyh-Ming, et al.
Publicado: (2016)

Helicobacter pylori eradication improves glycemic control in type 2 diabetes patients with asymptomatic active Helicobacter pylori infection
por: Cheng, Kai‐Pi, et al.
Publicado: (2019)

The impacts of H. pylori virulence factors on the development of gastroduodenal diseases
por: Chang, Wei-Lun, et al.
Publicado: (2018)

Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole
por: Tseng, Yen-Yu, et al.
Publicado: (2022)

Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2022)

First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2017)

Metabolic Interaction of Helicobacter pylori Infection and Gut Microbiota
por: Yang, Yao-Jong, et al.
Publicado: (2016)

H. pylori CagL-Y58/E59 Prime Higher Integrin α5β1 in Adverse pH Condition to Enhance Hypochlorhydria Vicious Cycle for Gastric Carcinogenesis
por: Yeh, Yi-Chun, et al.
Publicado: (2013)

Correction: H. pylori CagL-Y58/E59 Prime Higher Integrin α5β1 in Adverse pH Condition to Enhance Hypochlorhydria Vicious Cycle for Gastric Carcinogenesis
por: Yeh, Yi-Chun, et al.
Publicado: (2014)

Expressions of MMPs and TIMP-1 in Gastric Ulcers May Differentiate H. pylori-Infected from NSAID-Related Ulcers
por: Cheng, Hsiu-Chi, et al.
Publicado: (2012)

Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study
por: Chiang, Tsung-Hsien, et al.
Publicado: (2022)

Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions
por: Lee, Yi-Chia, et al.
Publicado: (2013)

Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands
por: Chiang, Tsung-Hsien, et al.
Publicado: (2021)

Helicobacter pylori Infection and Anemia in Taiwanese Adults
por: Shih, Hsiang-Yao, et al.
Publicado: (2013)

VCP Phosphorylation-Dependent Interaction Partners Prevent Apoptosis in Helicobacter pylori-Infected Gastric Epithelial Cells
por: Yu, Cheng-Chou, et al.
Publicado: (2013)

Associations of Circulating Gut Hormone and Adipocytokine Levels with the Spectrum of Gastroesophageal Reflux Disease
por: Tseng, Ping-Huei, et al.
Publicado: (2015)

Genome Sequence and Annotation of Helicobacter pylori Strain Hp238, Isolated from a Taiwanese Patient with Mucosa-Associated Lymphoid Tissue Lymphoma
por: Kao, Cheng-Yen, et al.
Publicado: (2015)

The Helicobacter pylori J99 jhp0106 Gene, under the Control of the CsrA/RpoN Regulatory System, Modulates Flagella Formation and Motility
por: Kao, Cheng-Yen, et al.
Publicado: (2017)

An extended 36-week oral esomeprazole improved long-term recurrent peptic ulcer bleeding in patients at high risk of rebleeding
por: Chiang, Hsueh-Chien, et al.
Publicado: (2022)

Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous Urticaria
por: Chiu, Yi-Chun, et al.
Publicado: (2013)

Association between Helicobacter pylori eradication and the risk of coronary heart diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2018)

Influence of Helicobacter pylori infection on risk of rheumatoid arthritis: a nationwide population-based study
por: Lee, Tzu-Hsuan, et al.
Publicado: (2023)

Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
por: Chen, Chieh-Chang, et al.
Publicado: (2020)

H. pylori clinical isolates have diverse babAB genotype distributions over different topographic sites of stomach with correlation to clinical disease outcomes
por: Sheu, Shew-Meei, et al.
Publicado: (2012)

Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention
por: Liou, Jyh-Ming, et al.
Publicado: (2019)

Eradication of Helicobacter pylori Is Associated with the Progression of Dementia: A Population-Based Study
por: Chang, Yang-Pei, et al.
Publicado: (2013)

Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia
por: Lee, Hsi-Chang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qcmh3v7v8b7f6jjj1dgt4jtktj